Navigation Links
Size does matter: Researchers adapt drug dosing to body size
Date:3/10/2008

University of Queensland researchers are leading the charge in adapting drug dosing to a society that is changing shape.

As the level of obesity in the Western World continues to rise dramatically, UQ School of Pharmacy's Dr Bruce Green says researchers face the ongoing challenge of determining just how dosages should be adjusted for different body sizes and compositions.

In a pharmacological sense, obesity presents a challenging role for clinicians, as the effects of altered body composition on the time course of drug response are poorly understood, Dr Green said.

[This] lack of dosing information [is of additional concern when you] consider that many of these individuals require therapeutic intervention for a variety of disease states.

It is this shortfall that the School of Pharmacy's Modelling and Simulation Group is looking to redress, as they work to optimise dosages for a variety of drugs in the overweight population.

The purpose of this study is linked to our overall strategy of ensuring that patients who are overweight do not get overdosed by dosing on total body weight, or underdosed by giving fixed doses to all patients, Dr Green said.

We propose that drugs should be dosed on our formula for lean body weight to match drug exposure across individuals of differing body compositions.

The results should minimise adverse events and improve efficacy of drugs, which we have already shown in an individualised dosing trial for enoxaparin (a blood thinning drug).


'/>"/>

Contact: Dr. Bruce Green
greenb@pharmacy.uq.edu.au
61-733-653-179
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Burroughs Wellcome Fund grants $9.75 million towards translational researchers
2. Researchers Design Promising Cancer Drug
3. Case Western Reserve University researchers identify colorectal cancer gene
4. On a roll: MIT researchers devise new cell-sorting system
5. Einstein researchers genetically engineer immune cells into potent weapons for battling HIV
6. Researchers control growth rate of replacement blood vessels, tissues
7. New protein discovery helps researchers understand autoimmune diseases
8. UF researchers warn parents about dangers of childhood foot burns
9. UCLA researchers find blood stem cells originate and are nurtured in the placenta
10. UCSF researchers validate new model for breast cancer risk assessment in multiple ethnic groups
11. Einstein researchers discover gene mutations linked to longer lifespans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: